GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (STU:S1R) » Definitions » ROC (Joel Greenblatt) %

Shanghai Pharmaceuticals Holding Co (STU:S1R) ROC (Joel Greenblatt) % : 17.80% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Shanghai Pharmaceuticals Holding Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 17.80%.

The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's ROC (Joel Greenblatt) % or its related term are showing as below:

STU:S1R' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 16.62   Med: 23.85   Max: 28.7
Current: 16.62

During the past 13 years, Shanghai Pharmaceuticals Holding Co's highest ROC (Joel Greenblatt) % was 28.70%. The lowest was 16.62%. And the median was 23.85%.

STU:S1R's ROC (Joel Greenblatt) % is ranked worse than
51.38% of 109 companies
in the Medical Distribution industry
Industry Median: 17.64 vs STU:S1R: 16.62

Shanghai Pharmaceuticals Holding Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 2.10% per year.


Shanghai Pharmaceuticals Holding Co ROC (Joel Greenblatt) % Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co ROC (Joel Greenblatt) % Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.81 22.40 24.83 25.75 18.65

Shanghai Pharmaceuticals Holding Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.50 5.98 21.88 19.90 17.80

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's ROC (Joel Greenblatt) %

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's ROC (Joel Greenblatt) % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's ROC (Joel Greenblatt) % falls into.



Shanghai Pharmaceuticals Holding Co ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(10365.701 + 4514.62 + 619.241) - (10105.829 + 0 + 951.025)
=4442.708

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(10577.922 + 4784.629 + 583.564) - (10330.965 + 0 + 975.749)
=4639.401

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Shanghai Pharmaceuticals Holding Co for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1226.544/( ( (2330.843 + max(4442.708, 0)) + (2367.357 + max(4639.401, 0)) )/ 2 )
=1226.544/( ( 6773.551 + 7006.758 )/ 2 )
=1226.544/6890.1545
=17.80 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pharmaceuticals Holding Co  (STU:S1R) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Shanghai Pharmaceuticals Holding Co ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co Business Description

Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2023, medical distribution is the largest segment, accounting for 89.8% of total revenue. It also has coverage of 31 provinces and cities nationwide.

Shanghai Pharmaceuticals Holding Co Headlines

No Headlines